Nuclera
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science researchers with easy access to target proteins.
Latest Content
Product News
Nuclera raises $12M To expand AI-powered protein platform
Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody expression, purification, and binding validation, enabling scalable, AI-driven biologics research.
Product News
Nuclera Expands eProtein Discovery Into Asia
Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University and National Cheng Kung University.
Industry Insight
Advancing Membrane Protein Research With Cell-Free Expression Systems
At the recent ELRIG Drug Discovery conference, Technology Networks spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.
Product News
Nuclera Expands eProtein Discovery Access in APAC Region
Nuclera partners with Solve Scientific to expand eProtein Discovery access across Australia, New Zealand and APAC markets.
App Note / Case Study
Speed Up Kinase Drug Target Characterization
This application note presents a next-generation approach to drug discovery - combining AI-guided structural design with rapid, automated digital microfluidics-based screening workflows that optimize protein expression. Researchers can obtain purifi
Product News
Nuclera and Cytiva Collaborate To Accelerate Characterization of Proteins for Drug Development
Nuclera and Cytiva collaborate to speed protein production and characterization, accelerating drug development workflows.
Product News
Nuclera Expands eProtein Discovery Capabilities To Enable Membrane Protein Production
Nuclera has enhanced its eProtein Discovery™ system with a new membrane protein workflow, offering rapid expression, purification, and stabilization of membrane proteins.
Industry Insight
Advancing Protein Prototyping Through Rapid and Efficient Systems
In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.
Webinar
Accelerating Drug Target Identification and Characterization
On-Demand
This webinar highlights how a streamlined workflow combining recombinant protein expression and interaction analysis accelerates drug–target screening, scaling, and characterization, improving efficiency and enabling faster decisions in drug discover
Product News
Nuclera’s eProtein Discovery System Installed at Domainex To Streamline Protein Production Services
Nuclera, and Domainex, announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.
Advertisement
